The following
is a sample of media coverage highlighting Amira milestones and events.
Date
Publication
Headline
Jun. 16, 2010
Xconomy
How to Find Balance in Biotech, Between Owning It All or Finding a Partner (LINK)
Mar. 29, 2010
BioWorld® Insight
“Hope ‘4-A’ Break in Asthma; FLAP Made Over New Bids” – BioWorld® Insight discusses new treatments being tested for asthma, including Amira’s 5-lipoxygenase activating protein (FLAP) inhibitors (LINK)
Mar. 22, 2010
The Pink Sheet
“InterMune Likely First To Market In IPF, But Other Firms Poised To Follow” – The Pink Sheet summarizes clinical and preclinical programs for treatment of IPF, including Amira’s LPA1 antagonist (LINK)
Jan. 28, 2010
Xconomy
Amira Mixes Small Biotech Irreverence, With Big Pharma Rigor, To Create New Lung Drugs
(LINK)
Developing a New Drug for Idiopathic Pulmonary Fibrosis
(PDF)
Jan. 12, 2010
Fierce Biotech
Bullish New Year's resolutions debut at the J.P. Morgan event
(LINK)
Nov. 11, 2009
Drug Discovery News
Viewing a partnership from both sides of the table (LINK)
Nov. 6, 2009
Pharmawire
Amira expects to finalize partnership deal for DP2 inhibitor program in coming months; to allow company to commercialize IPF compound on its own, CEO says
Sept. 17, 2009
Xconomy
How Biotechs Can Stand Out in the Competition for a Big Pharma Partnership (LINK)